Dimensional Fund Advisors LP Milestone Pharmaceuticals Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 39,450 shares of MIST stock, worth $95,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,450
Previous 39,450
-0.0%
Holding current value
$95,074
Previous $59,000
57.63%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
25.1MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$12 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$6.51 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$6.41 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$6.04 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$4.82 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $72.3M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...